Clinical Research Network

The OncoMethylome Sciences' clinical development program involves the collaboration with many of the world’s leading cancer research institutions.

These important relationships provide the company with clinical samples for testing and investigative interactions with key oncology opinion leaders. As more of our products are passing into late stage development, many retrospective and prospective trials are ongoing or being planned to clinically validate the utility of each diagnostic assay. OncoMethylome Sciences collaborates with a large number of academic and government medical centers and organizations in the USA, Europe, Canada and Australia including:

Johns Hopkins University Medical Institutions (USA)

Lovelace Respiratory Research Institute (USA)

Duke University Medical Center (USA)

Fox Chase Cancer Center (USA)

U.S. NCI’s Early Detection Research Network (EDRN, USA)

German Gastrointestinal Cancer Research Network (organized through Signature Diagnostics)

Cambridge University Medical Centre (UK)

The GROW Institute at the University Hospital of Maastricht (The Netherlands)